慢性淋巴细胞白血病的药理管理:当前和新兴疗法
Ivan J Huang1, Grace T Baek1, Chloe Siu1
1Department of Pharmacy, UW Medicine/Fred Hutchinson Cancer Center, Seattle, WA, USA.
Expert opinion on pharmacotherapy
|August 30, 2024
概括
向和细胞疗法已经彻底改变了慢性淋巴细胞白血病 (CLL) 或小淋巴细胞淋巴瘤 (SLL) 治疗,提供了更好的疗效和安全性. 未来的研究将重点关注这种无法治愈的恶性瘤的新组合和早期干预策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 慢性淋巴细胞白血病 (CLL) 或小淋巴细胞淋巴瘤 (SLL) 是一种惰的,无法治愈的B细胞恶性瘤.
- 在过去的十年里,CLL/SLL治疗的范式从化疗免疫疗法转向向和细胞疗法发生了转变.
- 这一转变是由新型治疗方法的提高疗效和改善安全概况所推动的.
研究的目的:
- 审查当前和新兴的CLL/SLL疗法的临床证据.
- 突出研究中的治疗方法和现有药物的新组合.
- 讨论不断变化的治疗环境和CLL/SLL管理的未来方向.
主要方法:
- 通过clinicaltrials.gov.gov识别的临床试验的系统审查.
- 在2024年6月进行了全面的PubMed文献搜索.
- 综合证据支持既有和新的治疗策略.
主要成果:
- 向疗法和免疫效应T细胞疗法显著改善了CLL/SLL的结果.
- 新型药物和组合疗法正在迅速出现,扩大治疗选择.
- 该评论总结了支持这些进展的临床数据.
结论:
- 新型CLL/SLL治疗方法的疗效和安全性需要进一步研究,特别是在早期干预方面.
- 仔细选择患者,考虑到并发症和治疗负担,对于优化治疗结果至关重要.
- 未来的研究应该专注于个性化治疗策略和管理癌症护理的财务毒性.
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:28Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:26Psychosis: Goals of Pharmacotherapy
113
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
113
01:19Antiasthma Drugs: Leukotriene Modifiers
253
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
253